Jim Simons Seres Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.93 - $2.15 $759,810 - $1.76 Million	817,000 New	817,000 $1.14 Million
Q1 2023 May 12, 2023	SELL	$4.95 - $6.09 $758,835 - $933,597	-153,300 Reduced 27.8%	398,200 $2.26 Million
Q4 2022 Feb 13, 2023	BUY	$5.09 - $9.05 $64,134 - $114,030	12,600 Added 2.34%	551,500 $3.09 Million
Q3 2022 Nov 14, 2022	SELL	$3.5 - $7.2 $1.18 Million - $2.43 Million	-337,507 Reduced 38.51%	538,900 $3.46 Million
Q2 2022 Aug 12, 2022	BUY	$2.7 - $7.62 $1.07 Million - $3.03 Million	397,007 Added 82.81%	876,407 $3.01 Million
Q1 2022 May 13, 2022	SELL	$6.3 - $8.84 $1.68 Million - $2.36 Million	-267,100 Reduced 35.78%	479,400 $3.41 Million
Q4 2021 Feb 11, 2022	BUY	$6.02 - $11.43 $4.49 Million - $8.53 Million	746,500 New	746,500 $6.22 Million
Q2 2021 Aug 13, 2021	SELL	$18.46 - $24.36 $2.39 Million - $3.15 Million	-129,200 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$17.66 - $28.92 $498,012 - $815,544	28,200 Added 27.92%	129,200 $2.66 Million
Q4 2020 Feb 10, 2021	SELL	$23.25 - $37.73 $6.41 Million - $10.4 Million	-275,808 Reduced 73.2%	101,000 $2.48 Million
Q3 2020 Nov 13, 2020	SELL	$3.74 - $28.74 $3.8 Million - $29.2 Million	-1,016,500 Reduced 72.96%	376,808 $10.7 Million
Q2 2020 Aug 13, 2020	BUY	$3.04 - $6.2 $962,160 - $1.96 Million	316,500 Added 29.39%	1,393,308 $6.63 Million
Q1 2020 May 14, 2020	SELL	$2.64 - $3.82 $101,904 - $147,452	-38,600 Reduced 3.46%	1,076,808 $3.84 Million
Q4 2019 Feb 13, 2020	BUY	$2.99 - $4.42 $108,238 - $160,004	36,200 Added 3.35%	1,115,408 $3.85 Million
Q3 2019 Nov 13, 2019	BUY	$2.29 - $4.16 $81,982 - $148,928	35,800 Added 3.43%	1,079,208 $4.33 Million
Q2 2019 Aug 12, 2019	BUY	$2.28 - $7.35 $321,936 - $1.04 Million	141,200 Added 15.65%	1,043,408 $3.36 Million
Q1 2019 May 14, 2019	BUY	$4.83 - $7.21 $469,959 - $701,533	97,300 Added 12.09%	902,208 $6.2 Million
Q4 2018 Feb 13, 2019	BUY	$4.52 - $8.88 $3.64 Million - $7.15 Million	804,908 New	804,908 $3.64 Million

Others Institutions Holding MCRB

# of Institutions

Shares Held

40.5M

Call Options Held

304K

Put Options Held

471K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$12.7 Million
3.73% of portfolio
Vanguard Group Inc Valley Forge, PA

6.06M
Shares

$3.33 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.76M
Shares

$969,186
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.39M
Shares

$763,751
0.0% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

1.19M
Shares

$656,011
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $68.2M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account